Liquid Handling Technology Market Size, Share & Trends Analysis Report By Product (Automated Liquid Handling, Manual Liquid Handling, Semi-Automated Liquid Handling), By Applications (Pharmaceutical and Biotechnology Industry, Diagnostic Centers, Research Institutes, Academic Institutes, Others), By End Use, By Region, and Segment Forecasts - 2035

Opportunity

""Compact automation and integrated genomic workflows are opening adoption to a wider laboratory base.""

The largest opportunity is the democratization of laboratory automation through smaller, more accessible platforms. Historically, full automation was concentrated in large pharmaceutical companies, centralized diagnostic laboratories, and high-throughput research facilities. New benchtop workstations are targeting laboratories that need automation but cannot justify the footprint or complexity of enterprise-scale systems. A compact liquid handler introduced in December 2025 provides 15 standard deck positions and 5 flexible positions, allowing low-to-medium throughput users to automate genomics, synthetic biology, gene expression, sequencing, cell-based assays, biochemical testing, and drug discovery. Semi-automated 96-channel instruments provide another entry point by enabling entire microplates to be pipetted simultaneously. These systems can support 96-well and 384-well formats and operating volumes from approximately 0.5 µL to 1,000 µL depending on the model. Such configurations allow laboratories to increase reproducibility without fully redesigning their existing workflows around large robotic systems.

Automation partnerships provide another important opportunity because life science customers increasingly prefer validated application packages rather than spending months creating protocols internally. Partnerships announced between 2025 and 2026 have targeted NGS library preparation, comprehensive genomic profiling, liquid biopsy sample preparation, nucleic acid extraction, and advanced PCR assays. These collaborations pair assay chemistry with automated pipetting protocols, reducing the technical barrier for laboratories implementing complex workflows. Acoustic dispensing creates additional potential because contactless technologies can move extremely small liquid volumes without disposable pipette tips. The acquisition of 2 automation specialists in July 2025 expanded one major company's capabilities in dynamic scheduling, integration, and acoustic dispensing. The combination of conventional air-displacement pipetting, acoustic transfer, robotic transport, and intelligent scheduling could create laboratories in which hundreds of samples move through multi-stage processes with very limited manual intervention.

Challenge

""Managing diverse liquids and maintaining accuracy across complex workflows remains technically demanding.""

The central technical challenge is that laboratory liquids behave differently depending on viscosity, surface tension, volatility, foaming tendency, temperature, and composition. Water-like buffers are relatively straightforward to transfer, but glycerol-rich solutions, organic solvents, protein mixtures, detergents, bead suspensions, and highly viscous reagents can require different aspiration speeds, dispense heights, prewetting steps, mixing patterns, and tip types. Modern systems therefore use software-defined liquid classes and liquid-level detection to optimize transfers. Even so, a platform that operates across a range from approximately 0.5 µL to 5,000 µL must maintain accuracy over a 10,000-fold volume span. Laboratories also need to manage variations between 96-well and 384-well geometries, where small positioning errors can create contamination or missed transfers. High-density automation increases throughput but makes setup errors more consequential because one incorrect parameter can affect hundreds of wells simultaneously.

Interoperability is another major challenge as laboratories increasingly connect liquid handlers with instruments from multiple manufacturers. A single automated cell may contain more than 10 hardware components, including dispensers, centrifuges, incubators, readers, sealers, storage modules, robotic arms, and analytical systems. Each component can use different software, communication protocols, plate definitions, and error states. Dynamic scheduling software helps coordinate these operations, but integration projects can still require specialized engineering and method validation. Acquisitions and partnerships are therefore becoming important competitive tools as manufacturers attempt to provide end-to-end automation. Laboratories must also manage data integrity when hundreds of plates and thousands of samples are processed automatically. Barcode identification, user permissions, audit trails, and automated result transfer are becoming essential for regulated diagnostic and pharmaceutical environments rather than optional software features.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The liquid handling technology market is segmented by product type into Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling. The application structure includes Pharmaceutical and Biotechnology Industry, Diagnostic Centers, Research Institutes, Academic Institutes, and Others. Automated Liquid Handling is estimated to represent approximately 58% of current demand, followed by Manual Liquid Handling at approximately 24% and Semi-Automated Liquid Handling at approximately 18%. Application demand is led by Pharmaceutical and Biotechnology Industry at approximately 41%, while Diagnostic Centers represent 20%, Research Institutes 17%, Academic Institutes 14%, and Others approximately 8%. The segmentation reflects an industry in which manual pipettes remain essential for flexible low-throughput tasks, but automated systems capture a growing share of higher-throughput and highly standardized workflows.

By Types

Automated Liquid Handling: Automated Liquid Handling accounts for approximately 58% market share and represents the largest product segment as laboratories prioritize throughput, repeatability, walk-away processing, and integration. Current workstations can provide 96-channel or 384-channel pipetting, robotic grippers, barcode scanning, liquid-level sensing, deck expansion, automated head exchange, and third-party instrument connectivity. High-end systems provide up to 45 deck positions and pipetting ranges between approximately 0.5 µL and 5,000 µL depending on configuration. Automated platforms are increasingly deployed for NGS library preparation, high-throughput screening, PCR setup, nucleic acid extraction, cell-based assays, ELISA, and compound handling. The segment is also benefiting from AI-enhanced software capable of simplifying protocol development and monitoring. Partnerships with genomic assay companies are strengthening adoption because users can deploy validated workflows more quickly instead of building each method from the beginning.

Manual Liquid Handling: Manual Liquid Handling represents approximately 24% market share and remains indispensable for flexible, low-volume, and exploratory laboratory work. Single-channel and multichannel pipettes are frequently used in academic laboratories, early-stage research, assay development, and applications where sample numbers do not justify automation. Manual instruments are available across volume ranges extending from fractions of a microliter to several milliliters and remain significantly easier to redeploy than fixed automation. However, repetitive pipetting can increase ergonomic strain and variation when operators process hundreds of wells per day. A standard 8-channel pipette requires 12 dispensing actions to fill one 96-well plate, while a 96-channel semi-automated or automated platform can complete the same plate pattern simultaneously. Manual systems are therefore expected to retain a substantial installed base while gradually losing share in standardized high-throughput applications.

Semi-Automated Liquid Handling: Semi-Automated Liquid Handling accounts for approximately 18% market share and occupies an important position between handheld pipettes and fully robotic workstations. These systems typically automate aspiration and dispensing while allowing the operator to position plates, choose programs, or move labware manually. Current 96-channel platforms can pipette complete 96-well plates and access 384-well plates through repeated indexing. One established platform provides a 0.5 µL to 300 µL operating range in its standard configuration, while an extended model reaches 1,000 µL. Performance at 1 µL can achieve random error below 3% and systematic error below 2%. Semi-automated devices are particularly attractive to Research Institutes, Academic Institutes, and smaller biotechnology laboratories because they improve reproducibility and ergonomics without requiring the space, integration effort, or capital associated with fully automated robotic platforms.

By Applications

Pharmaceutical and Biotechnology Industry: Pharmaceutical and Biotechnology Industry accounts for approximately 41% market share and represents the largest application because drug discovery and biological research contain many repetitive liquid-transfer processes. Compound screening, assay preparation, cell culture, genomic analysis, protein workflows, and formulation development can require hundreds or thousands of transfers per experiment. Modern automated workstations with 384-channel heads allow pharmaceutical laboratories to process entire high-density plates rapidly, while flexible volume ranges from sub-microliter quantities to several milliliters support multiple workflow stages. Biotechnology companies are increasingly using automated systems for NGS library preparation and synthetic biology, where reproducibility is essential. Partnerships announced through 2026 are expanding validated automation across sequencing, PCR, liquid biopsy, and genomic profiling workflows.

Diagnostic Centers: Diagnostic Centers represent approximately 20% market share and use liquid handling technology for sample preparation, molecular testing, PCR, immunoassays, nucleic acid extraction, normalization, and clinical research. Diagnostic workflows require accurate sample identification and consistent transfer because one processing error can affect patient-specific results. Automation can minimize direct human handling while improving traceability through barcode scanning and software-controlled workflows. High-throughput diagnostic laboratories may process hundreds or thousands of patient samples daily, making 96-channel processing especially valuable. Automated FFPE extraction platforms capable of processing up to 96 samples per day illustrate how specialized diagnostic sample preparation is moving toward walk-away operation. Demand is also supported by expanding oncology testing and genomic diagnostics.

Research Institutes: Research Institutes account for approximately 17% market share and require flexible liquid handling platforms that can support genomics, proteomics, drug discovery, cell biology, environmental testing, and multidisciplinary research. Unlike standardized clinical laboratories, research institutes frequently change protocols, making open software and modular hardware important purchasing factors. Systems with 20 or more deck positions can accommodate multiple consumables and instruments while allowing researchers to adapt methods as experiments evolve. Research laboratories also generate growing quantities of sequencing and screening data, encouraging adoption of higher-throughput 96-well and 384-well processing. Automation grants and shared instrumentation programs are helping institutions distribute expensive platforms across multiple research groups.

Academic Institutes: Academic Institutes represent approximately 14% market share and combine extensive manual pipetting with increasing adoption of compact and semi-automated systems. Budget constraints often prevent universities from installing enterprise automation in every laboratory, creating demand for shared platforms and benchtop systems. A compact workstation with 15 standard positions and 5 flexible positions is significantly easier to integrate into an academic laboratory than a full-scale system requiring approximately 170 centimeters of bench width. Semi-automated 96-channel devices also provide an accessible path to automation for PCR, ELISA, plate reformatting, cell seeding, and nucleic acid quantification. Academic demand is expected to increase as students and researchers become more familiar with robotics and reproducible workflow design.

Others: Others account for approximately 8% market share and include liquid handling requirements outside the major supplied application groups. Users in food testing, environmental analysis, chemical laboratories, agriculture-related testing, forensic science, and industrial research employ manual, semi-automated, and automated systems according to sample throughput. Environmental laboratories may process dozens or hundreds of extraction and dilution steps per batch, while agricultural research increasingly uses genomic and molecular techniques requiring microplate workflows. The broad category benefits from the increasing availability of configurable automation because new systems can combine more than 15 deck positions with interchangeable tools rather than requiring application-specific hardware.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to account for approximately 37% of global liquid handling technology demand, supported by extensive pharmaceutical R&D, biotechnology investment, molecular diagnostics, genomics laboratories, and research universities. The United States dominates regional adoption and has become a major launch environment for compact automation, integrated NGS workflows, and high-throughput laboratory systems. Automated workstations capable of supporting 45 deck positions are used across drug discovery and life science research, while smaller platforms with approximately 20 configurable positions are broadening automation among laboratories with moderate sample volumes. Demand is also influenced by increasing adoption of personalized medicine, where patient-specific genomic samples require highly traceable processing.

The region is characterized by extensive collaboration between assay developers and automation companies. During 2025 and the first half of 2026, multiple partnerships were announced for NGS library preparation, comprehensive genomic profiling, PCR assays, liquid biopsy, and sample amplification workflows. North American laboratories are also adopting contactless dispensing, intelligent scheduling, and integrated sample storage. Consolidation is reinforcing these capabilities, including the acquisition of 2 automation specialists by a major liquid handling manufacturer in July 2025. The U.S. therefore remains a key market for high-value automation even as equipment penetration rises in other regions.

Europe

Europe accounts for approximately 29% of liquid handling technology demand and maintains strong laboratory automation ecosystems in Germany, Switzerland, the United Kingdom, France, the Netherlands, Scandinavia, Italy, and other research-intensive markets. Pharmaceutical manufacturing, biotechnology, academic research, and molecular diagnostics generate substantial requirements for precise liquid handling. European laboratories also operate under demanding documentation and diagnostic quality requirements, increasing interest in software-controlled workflows and automated traceability. Platforms designed for regulated environments increasingly support compliance with CE-IVD and IVDR-related workflows while offering automated execution and digital monitoring.

Europe is also a major technology development center because several leading liquid handling companies maintain headquarters or significant operations within the region. Switzerland and Germany have particularly strong positions in robotic pipetting, laboratory instrumentation, and precision engineering. Semi-automated systems capable of simultaneously processing 96 channels have strong adoption among academic and research laboratories, while large pharmaceutical companies increasingly use 384-channel automation. European demand is also being influenced by sustainability objectives because laboratories want to reduce plastic consumables and energy use without compromising accuracy. Systems that selectively use fewer than 96 tips during partial-plate workflows can reduce unnecessary consumable consumption compared with fixed full-head processes.

Asia-Pacific

Asia-Pacific is estimated to represent approximately 27% market share and is projected to record the fastest expansion at around 6.2% annually. China, Japan, India, South Korea, Singapore, Australia, and other markets are expanding pharmaceutical research, genomic sequencing, diagnostic testing, and biotechnology infrastructure. China has developed large-scale sequencing and drug discovery capabilities, while India is increasing pharmaceutical research and molecular diagnostic capacity. Japan remains a major precision instrument market, and South Korea has expanded biotechnology and biopharmaceutical investment. These developments are creating demand for manual pipettes at entry-level laboratories and automated workstations in high-throughput facilities.

The region's growth is also supported by increasing localization of laboratory equipment sales, technical service, and application support. Automation manufacturers are expanding subsidiaries and distribution networks because reliable service is essential for robotic workstations. An established liquid handling company formally launched an Australian subsidiary in January 2025, strengthening direct regional support. Asia-Pacific laboratories are increasingly moving from manual workflows to semi-automated 96-channel systems before progressing to fully automated platforms. This staged adoption pattern creates opportunities across all 3 supplied product types rather than concentrating growth exclusively in large robotic installations.

Middle East & Africa

Middle East & Africa accounts for approximately 4% of liquid handling technology demand and remains an emerging automation market. Large hospitals, genomic centers, universities, and research institutions in the Gulf region are increasing investment in molecular diagnostics and biotechnology, while South Africa maintains an established biomedical research base. Demand is concentrated in major urban centers where laboratories handle sufficient sample volumes to justify automation. Semi-automated liquid handlers are particularly relevant because 96-channel processing can significantly increase throughput while requiring less infrastructure than large robotic systems.

Regional adoption remains constrained by service availability, laboratory budgets, consumable supply, and limited automation expertise. High-end instruments may require specialist maintenance and validated replacement components that are not always available locally. Nevertheless, national genomics and precision medicine programs are creating new demand. Laboratories processing more than 96 samples within repeated genomic workflows can achieve substantial operational benefits from automated extraction, normalization, and PCR setup. Expansion through 2035 is expected to be strongest in tertiary hospitals, centralized diagnostic facilities, and large research institutes.

List of Top Liquid Handling Technology Companies

• Agilent Technologies
• Aurora Biomed Inc.
• Beckman Coulter, Inc.
• Analytik Jena AG
• BioTek Instruments, Inc.
• Borosil Glass Works Ltd.
• Labnet International, Inc.
• Eppendorf AG
• Gilson, Inc.
• Hamilton Company
• LABCYTE INC.
• Tecan Trading AG

Top 2 Companies Market Share

Hamilton Company: Hamilton Company is estimated to hold approximately 17% share within the analyzed competitive structure, supported by its broad portfolio of automated liquid handling systems, precision pipetting technologies, software, consumables, storage automation, and integration capabilities. Its platforms support 96-channel and 384-channel liquid handling and are increasingly used for NGS, PCR, genomic profiling, drug discovery, and diagnostic sample preparation. During 2025, the company acquired 2 automation specialists to expand dynamic scheduling, system integration, and acoustic dispensing capabilities. It also announced several genomics partnerships during 2025 and 2026, strengthening its position in validated application-specific automation.

Beckman Coulter, Inc.: Beckman Coulter, Inc. is estimated to hold approximately 15% share within the same competitive structure, giving the top 2 participants a combined estimated share of approximately 32%. Its Biomek portfolio supports workstation configurations with up to 45 deck positions and 96-channel or 384-channel handling. In December 2025, the company expanded its portfolio with a compact benchtop system offering 15 standard positions and 5 flexible positions for low-to-medium throughput laboratories. Its broader liquid handling capabilities include acoustic dispensing and automated genomic workflows, supporting pharmaceutical, biotechnology, diagnostic, and research applications.

Investment Analysis

Investment in liquid handling technology is increasingly directed toward modular automation rather than isolated pipetting equipment. Pharmaceutical companies and centralized laboratories are investing in systems that can coordinate 5 or more process stages within a single automated workflow, including pipetting, shaking, incubation, separation, reading, and plate transport. Systems with up to 45 deck positions provide sufficient space for multiple reagents, microplates, reservoirs, and integrated devices, reducing operator intervention. Investment is also shifting toward software because workflow scheduling, data management, and remote monitoring determine how effectively several instruments can operate together. Automation suppliers are therefore acquiring integration expertise and developing application partnerships instead of relying exclusively on internally developed hardware.

Smaller laboratories represent an increasingly attractive investment area because compact automation expands the addressable customer base. A benchtop system with approximately 20 configurable deck positions can automate many molecular workflows without requiring the footprint of a workstation measuring around 170 centimeters in width. Semi-automated systems provide another investment pathway, allowing laboratories to process 96 channels simultaneously with substantially lower implementation complexity. Pharmaceutical and Biotechnology Industry users remain the primary investment group with approximately 41% application share, but Diagnostic Centers, Research Institutes, and Academic Institutes collectively account for more than 50% of the supplied application structure. Vendors that provide scalable platforms capable of expanding from basic pipetting to integrated automation can therefore capture customers as laboratory throughput increases.

New Product Development

New product development is focused on making automated liquid handling easier to deploy while increasing flexibility. In January 2025, a new automation platform was introduced with AI-enhanced workflow functionality, preconfigured methods, scalable hardware, and integrated analytics intended for laboratories of different sizes. In December 2025, another supplier launched a compact liquid handler with 15 standard deck positions and 5 flexible positions, targeting customers that need low-to-medium throughput automation. These products demonstrate a move away from the assumption that automated pipetting must involve large, specialist-operated robotic systems. Software interfaces are becoming more intuitive, while protocol templates reduce programming requirements and allow scientists to automate workflows without extensive robotics expertise.

Precision hardware is advancing simultaneously. New drive technologies are improving pipetting channel control, while 96-channel and 384-channel heads enable increasingly dense plate processing. Semi-automated platforms now use exchangeable dispensing heads to cover broad volume ranges while processing both 96-well and 384-well plates. Current systems can provide performance below 3% random error and below 2% systematic error at 1 µL, indicating the precision available from relatively compact equipment. Acoustic dispensing is also expanding because contactless transfer can minimize tip consumption and support very low-volume operations. Integration of acoustic technology with conventional pipetting platforms is likely to become an important development pathway as laboratories seek both high precision and reduced consumable dependence.

Five Recent Developments

• March 2026: Hamilton Company announced a partnership to automate next-generation sequencing library preparation workflows on its liquid handling platforms. The collaboration targets standardized sample preparation and increases access to automated genomic processing as laboratories transition from manual multistep workflows toward scalable 96-well automation.
• December 2025: Beckman Coulter, Inc. introduced the Biomek i3 Benchtop Liquid Handler for low-to-medium throughput laboratories. The compact workstation includes 15 standard deck positions and 5 flexible positions and supports applications including synthetic biology, sequencing, gene expression, screening, and drug discovery.
• July 2025: Hamilton Company acquired UK Robotics and Trisonic Discovery, adding 2 specialist automation businesses to its capabilities. The transaction expanded its portfolio into dynamic scheduling software, advanced systems integration, and precision acoustic dispensing for increasingly complex laboratory automation workflows.
• January 2025: Tecan Trading AG introduced the Veya liquid handling platform, combining AI-enhanced automation, prebuilt workflow functionality, digital analytics, and scalable configuration. The system was developed to support laboratories of different sizes and address complex applications including multiomics and regulated diagnostic workflows.
• July 2024: Hamilton Company expanded its compact automation offering around the Microlab Prep and introduced the Prep Clean Air Protection solution. The system provides HEPA and UV-related sample protection features while enabling benchtop automation for laboratories seeking to reduce manual pipetting and improve workflow consistency.

Report Coverage

The Liquid Handling Technology Market report evaluates industry conditions across the 2026-2035 forecast period using 2025 as the principal baseline. Coverage includes the supplied product types Automated Liquid Handling, Manual Liquid Handling, and Semi-Automated Liquid Handling and the applications Pharmaceutical and Biotechnology Industry, Diagnostic Centers, Research Institutes, Academic Institutes, and Others. Automated Liquid Handling is estimated to account for approximately 58% of product demand, followed by Manual Liquid Handling at 24% and Semi-Automated Liquid Handling at 18%. Application analysis places Pharmaceutical and Biotechnology Industry at approximately 41%, Diagnostic Centers at 20%, Research Institutes at 17%, Academic Institutes at 14%, and Others at approximately 8%. Regional analysis evaluates North America at approximately 37%, Europe at 29%, Asia-Pacific at 27%, Middle East & Africa at 4%, and Latin America at 3%.

The competitive assessment covers Agilent Technologies, Aurora Biomed Inc., Beckman Coulter, Inc., Analytik Jena AG, BioTek Instruments, Inc., Borosil Glass Works Ltd., Labnet International, Inc., Eppendorf AG, Gilson, Inc., Hamilton Company, LABCYTE INC., and Tecan Trading AG. Technology coverage examines workstations offering up to 45 deck positions, 96-channel and 384-channel pipetting, liquid transfer ranges extending from approximately 0.5 µL to 5,000 µL, compact systems with 20 configurable deck positions, and semi-automated platforms achieving below 3% random error at 1 µL. The report further assesses laboratory automation partnerships, NGS workflow integration, molecular diagnostics, acoustic dispensing, AI-enhanced protocol management, consumables, ergonomics, interoperability, regional adoption, investment priorities, product development, and the long-term transition from manual laboratory procedures toward connected automated workflows through 2035.